12 November 2018 19:35 CET

Offer to the shareholders of Karo Pharma Aktiebolag

#EQT VIII #Karo Pharma

For more information, click here.

Latest news

23 March 2023
EQT Growth invests EUR 100 million in IntegrityNext, a sustainability software platform dedicated to making supply chains more transparent and compliant
09 March 2023
EQT Life Sciences Co-leads $88 Million Series B Financing in QurAlis
03 March 2023
EQT Value-Add Infrastructure to acquire SK Shieldus, a leading South Korean integrated security operator
01 March 2023
EQT Active Core Infrastructure announces first investment to acquire Radius Global Infrastructure
21 February 2023
EQT strengthens its commitment to South Korea – opens new office in Seoul